Report cover image

Global Rifaximin Capsules Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 98 Pages
SKU # APRC20339383

Description

Summary

According to APO Research, The global Rifaximin Capsules market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Rifaximin Capsules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Rifaximin Capsules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Rifaximin Capsules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Rifaximin Capsules include Aden Healthcare, Alfasigma SpA, Estrellas Life Sciences Private Limited, Hainan Hailing Chemical Pharmaceutical Co., Ltd., Hainan Sanye Pharmaceutical Factory Co., Ltd., Shanghai Xinya Pharmaceutical Minhang Co., Ltd. and Southwest Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rifaximin Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rifaximin Capsules.
The Rifaximin Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rifaximin Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Rifaximin Capsules Segment by Company

Aden Healthcare
Alfasigma SpA
Estrellas Life Sciences Private Limited
Hainan Hailing Chemical Pharmaceutical Co., Ltd.
Hainan Sanye Pharmaceutical Factory Co., Ltd.
Shanghai Xinya Pharmaceutical Minhang Co., Ltd.
Southwest Pharmaceutical Co., Ltd.
Rifaximin Capsules Segment by Type

0.1g
0.2g
Rifaximin Capsules Segment by Application

Hospital
Clinic
Other
Rifaximin Capsules Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rifaximin Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rifaximin Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rifaximin Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rifaximin Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Rifaximin Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

98 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Rifaximin Capsules Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Rifaximin Capsules Sales Estimates and Forecasts (2020-2031)
1.3 Rifaximin Capsules Market by Type
1.3.1 0.1g
1.3.2 0.2g
1.4 Global Rifaximin Capsules Market Size by Type
1.4.1 Global Rifaximin Capsules Market Size Overview by Type (2020-2031)
1.4.2 Global Rifaximin Capsules Historic Market Size Review by Type (2020-2025)
1.4.3 Global Rifaximin Capsules Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Rifaximin Capsules Sales Breakdown by Type (2020-2025)
1.5.2 Europe Rifaximin Capsules Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Rifaximin Capsules Sales Breakdown by Type (2020-2025)
1.5.4 South America Rifaximin Capsules Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Rifaximin Capsules Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Rifaximin Capsules Industry Trends
2.2 Rifaximin Capsules Industry Drivers
2.3 Rifaximin Capsules Industry Opportunities and Challenges
2.4 Rifaximin Capsules Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Rifaximin Capsules Revenue (2020-2025)
3.2 Global Top Players by Rifaximin Capsules Sales (2020-2025)
3.3 Global Top Players by Rifaximin Capsules Price (2020-2025)
3.4 Global Rifaximin Capsules Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Rifaximin Capsules Major Company Production Sites & Headquarters
3.6 Global Rifaximin Capsules Company, Product Type & Application
3.7 Global Rifaximin Capsules Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Rifaximin Capsules Market CR5 and HHI
3.8.2 Global Top 5 and 10 Rifaximin Capsules Players Market Share by Revenue in 2024
3.8.3 2023 Rifaximin Capsules Tier 1, Tier 2, and Tier 3
4 Rifaximin Capsules Regional Status and Outlook
4.1 Global Rifaximin Capsules Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Rifaximin Capsules Historic Market Size by Region
4.2.1 Global Rifaximin Capsules Sales in Volume by Region (2020-2025)
4.2.2 Global Rifaximin Capsules Sales in Value by Region (2020-2025)
4.2.3 Global Rifaximin Capsules Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Rifaximin Capsules Forecasted Market Size by Region
4.3.1 Global Rifaximin Capsules Sales in Volume by Region (2026-2031)
4.3.2 Global Rifaximin Capsules Sales in Value by Region (2026-2031)
4.3.3 Global Rifaximin Capsules Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Rifaximin Capsules by Application
5.1 Rifaximin Capsules Market by Application
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Other
5.2 Global Rifaximin Capsules Market Size by Application
5.2.1 Global Rifaximin Capsules Market Size Overview by Application (2020-2031)
5.2.2 Global Rifaximin Capsules Historic Market Size Review by Application (2020-2025)
5.2.3 Global Rifaximin Capsules Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Rifaximin Capsules Sales Breakdown by Application (2020-2025)
5.3.2 Europe Rifaximin Capsules Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Rifaximin Capsules Sales Breakdown by Application (2020-2025)
5.3.4 South America Rifaximin Capsules Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Rifaximin Capsules Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Aden Healthcare
6.1.1 Aden Healthcare Comapny Information
6.1.2 Aden Healthcare Business Overview
6.1.3 Aden Healthcare Rifaximin Capsules Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Aden Healthcare Rifaximin Capsules Product Portfolio
6.1.5 Aden Healthcare Recent Developments
6.2 Alfasigma SpA
6.2.1 Alfasigma SpA Comapny Information
6.2.2 Alfasigma SpA Business Overview
6.2.3 Alfasigma SpA Rifaximin Capsules Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Alfasigma SpA Rifaximin Capsules Product Portfolio
6.2.5 Alfasigma SpA Recent Developments
6.3 Estrellas Life Sciences Private Limited
6.3.1 Estrellas Life Sciences Private Limited Comapny Information
6.3.2 Estrellas Life Sciences Private Limited Business Overview
6.3.3 Estrellas Life Sciences Private Limited Rifaximin Capsules Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Estrellas Life Sciences Private Limited Rifaximin Capsules Product Portfolio
6.3.5 Estrellas Life Sciences Private Limited Recent Developments
6.4 Hainan Hailing Chemical Pharmaceutical Co., Ltd.
6.4.1 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Comapny Information
6.4.2 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Business Overview
6.4.3 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Rifaximin Capsules Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Rifaximin Capsules Product Portfolio
6.4.5 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Recent Developments
6.5 Hainan Sanye Pharmaceutical Factory Co., Ltd.
6.5.1 Hainan Sanye Pharmaceutical Factory Co., Ltd. Comapny Information
6.5.2 Hainan Sanye Pharmaceutical Factory Co., Ltd. Business Overview
6.5.3 Hainan Sanye Pharmaceutical Factory Co., Ltd. Rifaximin Capsules Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hainan Sanye Pharmaceutical Factory Co., Ltd. Rifaximin Capsules Product Portfolio
6.5.5 Hainan Sanye Pharmaceutical Factory Co., Ltd. Recent Developments
6.6 Shanghai Xinya Pharmaceutical Minhang Co., Ltd.
6.6.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Comapny Information
6.6.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Business Overview
6.6.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Rifaximin Capsules Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Rifaximin Capsules Product Portfolio
6.6.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Recent Developments
6.7 Southwest Pharmaceutical Co., Ltd.
6.7.1 Southwest Pharmaceutical Co., Ltd. Comapny Information
6.7.2 Southwest Pharmaceutical Co., Ltd. Business Overview
6.7.3 Southwest Pharmaceutical Co., Ltd. Rifaximin Capsules Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Southwest Pharmaceutical Co., Ltd. Rifaximin Capsules Product Portfolio
6.7.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
7.1 North America Rifaximin Capsules Sales by Country
7.1.1 North America Rifaximin Capsules Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Rifaximin Capsules Sales by Country (2020-2025)
7.1.3 North America Rifaximin Capsules Sales Forecast by Country (2026-2031)
7.2 North America Rifaximin Capsules Market Size by Country
7.2.1 North America Rifaximin Capsules Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Rifaximin Capsules Market Size by Country (2020-2025)
7.2.3 North America Rifaximin Capsules Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Rifaximin Capsules Sales by Country
8.1.1 Europe Rifaximin Capsules Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Rifaximin Capsules Sales by Country (2020-2025)
8.1.3 Europe Rifaximin Capsules Sales Forecast by Country (2026-2031)
8.2 Europe Rifaximin Capsules Market Size by Country
8.2.1 Europe Rifaximin Capsules Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Rifaximin Capsules Market Size by Country (2020-2025)
8.2.3 Europe Rifaximin Capsules Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Rifaximin Capsules Sales by Country
9.1.1 Asia-Pacific Rifaximin Capsules Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Rifaximin Capsules Sales by Country (2020-2025)
9.1.3 Asia-Pacific Rifaximin Capsules Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Rifaximin Capsules Market Size by Country
9.2.1 Asia-Pacific Rifaximin Capsules Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Rifaximin Capsules Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Rifaximin Capsules Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Rifaximin Capsules Sales by Country
10.1.1 South America Rifaximin Capsules Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Rifaximin Capsules Sales by Country (2020-2025)
10.1.3 South America Rifaximin Capsules Sales Forecast by Country (2026-2031)
10.2 South America Rifaximin Capsules Market Size by Country
10.2.1 South America Rifaximin Capsules Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Rifaximin Capsules Market Size by Country (2020-2025)
10.2.3 South America Rifaximin Capsules Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Rifaximin Capsules Sales by Country
11.1.1 Middle East and Africa Rifaximin Capsules Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Rifaximin Capsules Sales by Country (2020-2025)
11.1.3 Middle East and Africa Rifaximin Capsules Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Rifaximin Capsules Market Size by Country
11.2.1 Middle East and Africa Rifaximin Capsules Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Rifaximin Capsules Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Rifaximin Capsules Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Rifaximin Capsules Value Chain Analysis
12.1.1 Rifaximin Capsules Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Rifaximin Capsules Production Mode & Process
12.2 Rifaximin Capsules Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Rifaximin Capsules Distributors
12.2.3 Rifaximin Capsules Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.